Naga Venkata Ravi Kumar Majeti (M N V Ravi Kumar, Majeti N V Ravi Kumar)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

ACS nano

Pharmacological reviews

ACS chemical neuroscience

ACS pharmacology & translational science

Texas A&M University

Indian Institute of Technology Roorkee (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Texas A&M University

United States

Professor :: Pharmaceutics

University of Strathclyde

United Kingdom

Professor of Drug Delivery :: Institute of Pharmacy and Biomedical Sciences

National Institute of Pharmaceutical Education and Research

India

Assistant Professor :: Pharmaceutics

Education History

Indian Institute of Technology Roorkee

India

PHD :: Chemistry

Publications

Ingrid Marie Heyns, Alina Farah Faunce, Mercy Ngosa Mumba, Naga Venkata Ravi Kumar Majeti, Meenakshi Arora
Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction. ACS pharmacology & translational science 7 (8) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
K T Babalola, Meenakshi Arora, Raghu Ganugula, S K Agarwal, C Mohan, Naga Venkata Ravi Kumar Majeti
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes. Pharmacological reviews 76 (2) (2024)
K T Babalola, Meenakshi Arora, Raghu Ganugula, S K Agarwal, C Mohan, Naga Venkata Ravi Kumar Majeti
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes. Pharmacological reviews 76 (2) (2024)
K T Babalola, Meenakshi Arora, Raghu Ganugula, S K Agarwal, C Mohan, Naga Venkata Ravi Kumar Majeti
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes. Pharmacological reviews 76 (2) (2024)
K T Babalola, Meenakshi Arora, Raghu Ganugula, S K Agarwal, C Mohan, Naga Venkata Ravi Kumar Majeti
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes. Pharmacological reviews 76 (2) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Ingrid Marie Heyns, Alina Farah Faunce, Mercy Ngosa Mumba, Naga Venkata Ravi Kumar Majeti, Meenakshi Arora
Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction. ACS pharmacology & translational science 7 (8) (2024)
K T Babalola, Meenakshi Arora, Raghu Ganugula, S K Agarwal, C Mohan, Naga Venkata Ravi Kumar Majeti
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes. Pharmacological reviews 76 (2) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano (2024)
Raghu Ganugula, M Arora, S Dwivedi, D S Chandrashekar, S Varambally, E M Scott, Naga Venkata Ravi Kumar Majeti
Systemic Anti-Inflammatory Therapy Aided by Curcumin-Laden Double-Headed Nanoparticles Combined with Injectable Long-Acting Insulin in a Rodent Model of Diabetes Eye Disease. ACS nano (2023)
Ingrid M Heyns, Raghu Ganugula, Tanmaykumar Varma, Swetha Reddy Allamreddy, Navneet Kumar, Prabha Garg, Naga Venkata Ravi Kumar Majeti, Meenakshi Arora
Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin. ACS applied materials & interfaces (2023)
Srijayaprakash Uppada, Dianxiong Zou, Erin M Scott, Gladys Ko, Stephen Pflugfelder, Naga Venkata Ravi Kumar Majeti, Raghu Ganugula
Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an Ex Vivo Rat Eye Model. ACS chemical neuroscience 13 (14) (2022)
Raghu Ganugula, Meenakshi Arora, M A Lepiz, Y Niu, B K Mallick, S C Pflugfelder, Erin M Scott, Naga Venkata Ravi Kumar Majeti
Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Science advances 6 (35) (2020)
Caitlin A Madison, Meenakshi Arora, Naga Venkata Ravi Kumar Majeti, Shoshana Eitan
Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice. ACS chemical neuroscience 11 (13) (2020)
Raghu Ganugula, Meenakshi Arora, Dianxiong Zou, Sandeep K Agarwal, Chandra Mohan, Naga Venkata Ravi Kumar Majeti
A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. Science advances 6 (24) (2020)
M Arora, Raghu Ganugula, N Kumar, G Kaur, Jean-Philippe Pellois, Prabha Garg, Naga Venkata Ravi Kumar Majeti
Next-Generation Noncompetitive Nanosystems Based on Gambogic Acid: In silico Identification of Transferrin Receptor Binding Sites, Regulatory Shelf Stability, and Their Preliminary Safety in Healthy Rodents. ACS applied bio materials 2 (8) (2019)
Raghu Ganugula, M Deng, M Arora, H-L Pan, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy. ACS chemical neuroscience 10 (3) (2019)
Raghu Ganugula, Meenakshi Arora, Melissa Guada, Prabhjot Saini, Naga Venkata Ravi Kumar Majeti
Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform. ACS macro letters 6 (2) (2017)
Raghu Ganugula, Meenakshi Arora, Naga Venkata Ravi Kumar Majeti
Ex Vivo Rat Eye Model for Investigating Transport of Next Generation Precision-Polyester Nanosystems. ACS applied materials & interfaces 9 (31) (2017)
Raghu Ganugula, Meenakshi Arora, Patcharawalai Jaisamut, Ruedeekorn Wiwattanapatapee, Heather G Jørgensen, Vinod P Venkatpurwar, Beiyan Zhou, Aline Rodrigues Hoffmann, Rita Basu, Shaodong Guo, Naga Venkata Ravi Kumar Majeti
Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus. British journal of pharmacology 174 (13) (2017)
Raghu Ganugula, Meenakshi Arora, Prabhjot Saini, Melissa Guada, Naga Venkata Ravi Kumar Majeti
Next Generation Precision-Polyesters Enabling Optimization of Ligand-Receptor Stoichiometry for Modular Drug Delivery. Journal of the American Chemical Society 139 (21) (2017)

Naga Venkata Ravi Kumar Majeti.css-eqlu8i{font-size:small;padding-left:4px;} (M N V Ravi Kumar, Majeti N V Ravi Kumar)

Publication Activity (10 Years)

Top Topics

Top Venues

Naga Venkata Ravi Kumar Majeti (M N V Ravi Kumar, Majeti N V Ravi Kumar)